Outcome and survival of asymptomatic PML in natalizumab-treated MS patients

OBJECTIVE: As of 3 September 2013, 399 cases of natalizumab-associated progressive multifocal leukoencephalopathy (PML) were confirmed in multiple sclerosis (MS) patients. We evaluated outcomes of natalizumab-treated MS patients who were asymptomatic at PML diagnosis. METHODS: Analyses included data...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Clin Transl Neurol
Hlavní autoři: Dong-Si, Tuan, Richman, Sandra, Wattjes, Mike P, Wenten, Made, Gheuens, Sarah, Philip, Jeffrey, Datta, Shoibal, McIninch, James, Bozic, Carmen, Bloomgren, Gary, Richert, Nancy
Médium: Artigo
Jazyk:Inglês
Vydáno: BlackWell Publishing Ltd 2014
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4241803/
https://ncbi.nlm.nih.gov/pubmed/25493267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.114
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky